You are here

Home > Current news > News > Companies

Companies

Reig Jofre i Maruishi Pharma

Reig Jofre begins exporting to Japan

25.02.2016

The company has gained approval to sell a sterile injectable for hospital use, which it will market through Maruishi Pharma

Subtilis Biomaterials to launch bone-regeneration products

19.02.2015

The company was one of the finalists in the latest edition of the BioEmprenedorXXI awards

Directius de ThermiGen i Almirall

Almirall enters aesthetics market, acquiring ThermiGen

17.02.2016

The pharmaceutical company has acquired the US firm for enterprise value of €73 millions

BIO Europe Spring

20 Catalan organizations to participate in BIO-Europe Spring 2016 in Stockholm

11.02.2016

Companies and organizations from the BioRegion of Catalonia are eligible for €200 off registration fees

César Molinero

Oryzon Genomics starts clinical trial on molecule to treat Alzheimer

04.02.2016

The study will be conducted at Hospital Sant Pau Barcelona and the company will continue researching the effectiveness of the compound on other neurodegenerative diseases

Dr. Khalid Islam

Minoryx appoints new chairman of board of directors

02.02.2016

Dr. Khalid Islam has extensive experience in the pharmaceutical and biotechnology industry and the company believes he can lead them to great successes

15 forum inversió healthcare

The 16th Healthcare Investment Forum to bring together investors and health entrepreneurs

28.01.2016

La convocatoria para presentar proyectos está actualmente abierta y finaliza el 25 de febrero

Seu Isdin

Isdin enters United States and expands in Latin America

04.01.2016

The Catalan pharmaceutical company closed 2014 with turnover up 10.4% and profit of 68%

Victor Grífols

Víctor Grífols to step down, leaving son and brother at helm of company

16.12.2015

The group has announced that the succession plan will be rolled out over the coming year

SOM Biotech i Vall d’Hebron assaig clínic fàrmac amiloïdosi

SOM Biotech and Vall d’Hebron successfully complete clinical trial in patients with amyloidosis drug

20.11.2015

It is a rare disease that affects the nervous system and heart, with only one treatment in the world

Developed by Drauta